Related Experiment Video
Updated: Aug 12, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Prognostic significance of myocardial enzyme release after coronary interventions
1Department of Medicine, Columbia Presbyterian Medical Center, New York, NY 10032, USA.
Insights
Mild elevations in cardiac enzymes after procedures increase risks of heart attack and death. These risks must be weighed against alternative treatments and continued medical management for patients undergoing percutaneous revascularization.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Periprocedural myocardial injury, indicated by elevated creatine kinase (CK) and CK-myocardial band (MB), is a recognized complication.
- The clinical significance of mild to moderate enzyme elevations following percutaneous revascularization remains incompletely understood.
Purpose of the Study:
- To evaluate the prognostic implications of periprocedural creatine kinase (CK) and CK-myocardial band (MB) elevations.
- To inform risk-benefit assessments for percutaneous revascularization versus alternative management strategies.
Main Methods:
- Analysis of clinical data correlating periprocedural enzyme levels with subsequent cardiac events.
- Review of existing literature on periprocedural myocardial injury and long-term outcomes.
Main Results:
- Mild to moderate elevations in CK and CK-MB post-procedure are associated with increased risk of subsequent myocardial infarction.
- These enzyme elevations correlate with higher mortality rates.
Conclusions:
- Periprocedural enzyme elevations are significant indicators of future cardiac events and mortality.
- Clinical decisions regarding percutaneous revascularization must consider these risks alongside alternative treatments and ongoing medical management.
- Further prospective studies are needed to fully elucidate the long-term prognosis associated with periprocedural enzyme elevations.
Abstract:
Mild to moderate periprocedural elevation in CK with concurrent CK MB elevation result in increased subsequent myocardial infarction and mortality. However the potential risks that percutaneous revascularization interventions pose must be evaluated in light the risks of alternative procedures and the risks of continued medical management. Prospective clinical trials examining the relationship of periprocedural enzyme elevations to long term prognosis will need to address this issue.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

